-
Sat05Sep2026Wed09Sep2026
-
Thu10Sep2026
-
Thu01Oct2026Sat03Oct2026
-
Sat03Oct2026Sun04Oct2026
-
Sun04Oct2026Wed07Oct2026
-
Tue06Oct2026Fri09Oct2026
-
Wed14Oct2026Fri16Oct2026Santiago de Compostela, Spain
-
Tue17Nov2026Sat21Nov2026
Latest News
Vexev secures funding to advance US commercialisation of VxWave
Australian medical robotics company Vexev has announced it has raised US$6 million in new funding to accelerate the path to US Food and Drug...
Features
Rethinking interventions for asymptomatic carotid stenosis
Caitlin Hicks (Baltimore, USA) reflects on CREST-2 following publication of the trial late last year.
After nearly a decade of enrolment and follow-up, CREST-2 provides...
From the operating theatre to Westminster, PAD needs a unifying voice
In the first of a series of regular columns, Rachael Forsythe (Edinburgh, UK) provides an update from the Circulation Foundation—the UK’s only national charity...
Videos
A group of leading carotid disease specialists representing interventional cardiology and vascular surgery discuss what CREST-2 means for the treatment of asymptomatic carotid stenosis.
Watch the full-length discussion here.
